InvestorsHub Logo
Followers 117
Posts 20248
Boards Moderated 0
Alias Born 06/13/2011

Re: ErnieBilco post# 1451

Saturday, 03/23/2024 6:53:31 PM

Saturday, March 23, 2024 6:53:31 PM

Post# of 1489
If they were only selling IBSRELA they would probably have been bt out already or negotiating a sale now. That drug has found a niche and is in demand.
Xphazoh is the unknown and may depend on what happens with UNCY's final trial with OLC .

If the final OLC trial succeeds ...that Co ( UNCY ) is very likely to be sold. Then the buyer will price OLC as less expensive then X ...for all those who hate the generics, and can afford the co pay of the new brand phosphorous lowering drugs.
OLC is 3 small pills a day swallowed with meals
X is 2 small pills ...1 in am , 1 in pm.
The advantage of OLC is that its a " condensed " version of Fosrenol ... a drug my wife already prescribes , so an easy transition

JMO
Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ARDX News